diatrizoate meglumine has been researched along with gadolinium in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beam, CA; Cohan, RH; Dunnick, NR; Hedlund, LW; Herzberg, AJ; Leder, RA; Nadel, SN; Wheeler, CT | 1 |
| Hayakawa, K; Mitsumori, M; Nakano, Y; Yamashita, K | 1 |
| Hajek, PC; Neumann, CH; Resnick, D; Sartoris, DJ | 1 |
| Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
| Baxter, AB; Brasch, RC; Lazarus, SC | 1 |
| Araki, Y; Furukawa, T; Higashino, K; Sakaguchi, K; Ueda, J; Ujita, H; Yamamoto, T | 1 |
| Beckmann, R; Lehr, R; Weinmann, HJ; Wiggins, J | 1 |
| Hayakawa, K; Nakamura, T; Shimizu, Y | 1 |
8 other study(ies) available for diatrizoate meglumine and gadolinium
| Article | Year |
|---|---|
Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
Topics: Animals; Contrast Media; Diatrizoate Meglumine; Extravasation of Diagnostic and Therapeutic Materials; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Diatrizoate Meglumine; Female; Gadolinium; Gadolinium DTPA; Iohexol; Ioxaglic Acid; Magnetic Resonance Imaging; Male; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rabbits; Radiography; Triiodobenzoic Acids | 1990 |
Potential contrast agents for MR arthrography: in vitro evaluation and practical observations.
Topics: Air; Contrast Media; Diatrizoate Meglumine; Gadolinium; Gadolinium DTPA; Humans; In Vitro Techniques; Joint Diseases; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Serum Albumin; Sodium Chloride; Synovial Fluid | 1987 |
Multiple sclerosis: gadolinium enhancement in MR imaging.
Topics: Adult; Aged; Contrast Media; Diatrizoate Meglumine; Female; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Pentetic Acid; Tomography, X-Ray Computed | 1986 |
In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
Topics: Anaphylaxis; Animals; Cell Line; Contrast Media; Diatrizoate Meglumine; Dogs; Gadolinium; Gadolinium DTPA; Histamine Release; In Vitro Techniques; Iohexol; Magnetic Resonance Imaging; Mannitol; Mast Cells; Mastocytosis; Organometallic Compounds; Pentetic Acid | 1993 |
Permeability of iodinated and MR contrast media through two types of hemodialysis membrane.
Topics: Chromatography, High Pressure Liquid; Contrast Media; Diatrizoate Meglumine; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; In Vitro Techniques; Iopamidol; Ioxaglic Acid; Magnetic Resonance Imaging; Membranes, Artificial; Organometallic Compounds; Permeability; Renal Dialysis | 1999 |
Electrocardiographic effects of diagnostic imaging agents.
Topics: Action Potentials; Animals; Contrast Media; Coronary Angiography; Diatrizoate Meglumine; Dogs; Electrocardiography; Gadolinium; Gadolinium DTPA; Guinea Pigs; Hemodynamics; Heterocyclic Compounds; Humans; Iohexol; Organometallic Compounds; Prospective Studies; Risk Factors | 2002 |
Calcium binding by gadolinium-based MR contrast agents.
Topics: Calcium; Contrast Media; Diatrizoate Meglumine; Gadolinium; Ions; Magnetic Resonance Imaging; Organometallic Compounds; Potassium; Sodium | 2005 |